נגישות
menu      
Advanced Search
Syntax
Search...
Volcani treasures
About
Terms of use
Manage
Community:
אסיף מאגר המחקר החקלאי
Powered by ClearMash Solutions Ltd -
Photodynamic therapy of age-related macular degeneration and atherosclerosis
Year:
1989
Authors :
Rosenthal, Ionel
;
.
Volume :
93
Co-Authors:
Ben-Hur, E., Nuclear Research Cent-Negev, Israel
Miller, H., Nuclear Research Cent-Negev, Israel
Miller, B., Nuclear Research Cent-Negev, Israel
Rosenthal, I., Nuclear Research Cent-Negev, Israel
Facilitators :
From page:
284
To page:
286
(
Total pages:
3
)
Abstract:
In photodynamic therapy, a photosensitizing dye restrictively localized to certain sites in the biological milieu, is activated by visible light to selectively destroy the stained structure. Although primarily investigated for necroting malignant tumors, this approach also suggests potential in treating other pathological conditions such as age-related macular degeneration and atherosclerosis. Until recently, hematoporphyring derivative was practically the only dye investigated for photodynamic therapy. The use of phthalocyanine dyes is being explored as a superior alternative photosensitizer for treatment of these diseases.
Note:
Related Files :
Age-Related Macular Degeneration
Atherosclerosis
BIOMEDICAL ENGINEERING
Fluorescence
Show More
Related Content
More details
DOI :
Article number:
Affiliations:
Database:
Scopus
Publication Type:
article
;
.
Language:
English
Editors' remarks:
ID:
29214
Last updated date:
02/03/2022 17:27
Creation date:
17/04/2018 00:45
Scientific Publication
Photodynamic therapy of age-related macular degeneration and atherosclerosis
93
Ben-Hur, E., Nuclear Research Cent-Negev, Israel
Miller, H., Nuclear Research Cent-Negev, Israel
Miller, B., Nuclear Research Cent-Negev, Israel
Rosenthal, I., Nuclear Research Cent-Negev, Israel
Photodynamic therapy of age-related macular degeneration and atherosclerosis
In photodynamic therapy, a photosensitizing dye restrictively localized to certain sites in the biological milieu, is activated by visible light to selectively destroy the stained structure. Although primarily investigated for necroting malignant tumors, this approach also suggests potential in treating other pathological conditions such as age-related macular degeneration and atherosclerosis. Until recently, hematoporphyring derivative was practically the only dye investigated for photodynamic therapy. The use of phthalocyanine dyes is being explored as a superior alternative photosensitizer for treatment of these diseases.
Scientific Publication
You may also be interested in